4//SEC Filing
Sagent Pharmaceuticals, Inc. 4
Accession 0000899243-16-028302
CIK 0001369786operating
Filed
Aug 30, 8:00 PM ET
Accepted
Aug 31, 6:21 PM ET
Size
19.1 KB
Accession
0000899243-16-028302
Insider Transaction Report
Form 4
FEKETE MICHAEL
Director
Transactions
- Disposition to Issuer
Common Stock
2016-08-29$21.75/sh−2,283$49,655→ 2,041 total - Disposition from Tender
Common Stock
2016-08-29$21.75/sh−2,041$44,392→ 0 total - Disposition to Issuer
Restricted Stock Units
2016-08-29$21.75/sh−691$15,029→ 0 total→ Common Stock (691 underlying) - Disposition to Issuer
Restricted Stock Units
2016-08-29$21.75/sh−592$12,876→ 0 total→ Common Stock (592 underlying) - Disposition to Issuer
Restricted Stock Units
2016-08-29$21.75/sh−8,556$186,093→ 0 total→ Common Stock (8,556 underlying) - Disposition to Issuer
Restricted Stock Units
2016-08-29$21.75/sh−1,381$30,037→ 0 total→ Common Stock (1,381 underlying) - Disposition to Issuer
Restricted Stock Units
2016-08-29$21.75/sh−1,860$40,455→ 0 total→ Common Stock (1,860 underlying)
Footnotes (9)
- [F1]Pursuant to the Agreement and Plan of Merger by and among Nichi-Iko Pharmaceutical Co. Ltd., Shepard Vision, Inc. and Sagent Pharmaceuticals, Inc. (the "Merger Agreement"), these shares were canceled and converted into the right to receive $21.75 per share in cash, without interest, less any applicable withholding taxes (the "Consideration").
- [F2]Pursuant to the Merger Agreement, these shares were disposed of in a cash tender offer by Shepard Vision, Inc. to acquire common stock of Sagent Pharmaceuticals, Inc. in exchange for the Consideration.
- [F3]Each restricted stock unit represents a contingent right to receive one share of SGNT common stock.
- [F4]The restricted stock units provided for vesting on February 22, 2017.
- [F5]Each restricted stock unit was disposed pursuant to the Merger Agreement whereby each such restricted stock unit was cancelled and converted into the right to receive the Consideration.
- [F6]The restricted stock units provided for vesting in four equal annual installments beginning on April 9, 2016.
- [F7]The restricted stock units provided for vesting in four equal annual installments beginning on February 25, 2016.
- [F8]The restricted stock units provided for vesting in four equal annual installments beginning on February 18, 2015.
- [F9]The restricted stock units provided for vesting in four equal annual installments beginning on July 10, 2014.
Documents
Issuer
Sagent Pharmaceuticals, Inc.
CIK 0001369786
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001369786
Filing Metadata
- Form type
- 4
- Filed
- Aug 30, 8:00 PM ET
- Accepted
- Aug 31, 6:21 PM ET
- Size
- 19.1 KB